HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hain Celestial adds Avalon

This article was originally published in The Rose Sheet

Executive Summary

Hain Celestial will acquire Avalon Natural Products, including the Avalon Organics and Alba Botanica personal care brands, from North Castle Partners private equity firm for $120 million in cash, company announces Dec. 18. Subject to approval, the transaction is expected to close in early 2007 and be accretive to the firm's fiscal year 2008 earnings. Avalon and Alba are expected to "strengthen Hain Celestial as one of the leading natural and organic personal care products companies in a category that is experiencing double-digit growth," company President and CEO Irwin D. Simon said. With Alba and Avalon exceeding $40 million in sales for FY 2006, the exec expects Hain Celestial to have "a strong foundation in the personal care market with sales of $125 million." Hain Celestial's portfolio includes the Jason, Zia Natural Skincare and Queen Helene brands...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014432

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel